Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

(2011) M. Di Ianni et al.   BLOOD

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

(2010) C. G. Brunstein et al.   BLOOD

Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells

(2009) Jakub Tolar et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rapamycin enhances lifespan: At last, an advantage for transplant recipients?

(2009) E. K. Geissler   NEPHROLOGY DIALYSIS TRANSPLANTATION

Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin

(2009) Laura Strauss et al.   PLoS One

Rapamycin-treated mature dendritic cells have a unique cytokine secretion profile and impaired allostimulatory capacity

(2009) Guo-Ying Wang et al.   TRANSPLANT INTERNATIONAL

Mechanisms regulating the development and function of natural regulatory T cells

(2008) Sonal Gupta et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells

(2008) P. Monti et al.   DIABETES

Critical role of IL-2 and TGF-β in generation, function and stabilization of Foxp3+CD4+ Treg

(2008) David A. Horwitz et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells

(2008) Susan Brandenburg et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells

(2008) S. Alice Long et al.   JOURNAL OF AUTOIMMUNITY

De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR

(2008) Johnthomas Kang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Novel approaches to imatinib-and sunitinib-resistant GIST

(2008) Peter Reichardt   Current Oncology Reports

IL-2 signaling and CD4+CD25+Foxp3+ regulatory T cells

(2007) Laurence et al.   Frontiers in Bioscience-Landmark